HACKENSACK MERIDIAN HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 2016-01-01

Employees: -

Market Cap: -

Website: https://www.hackensackmeridianhealth.org/

Clinical Trials

A Prospective "Universal" Observational Database for COVID-19

Conditions: COVID-19

First Posted Date: 2020-04-15

Last Posted Date: 2022-05-12

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 4496

Registration Number: NCT04347993

Locations: 🇺🇸
Hackensack Meridian Health - John Theurer Cancer Center, Hackensack, New Jersey, United States

Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers

Phase 2

Completed

Conditions: Covid19

Interventions: Drug: Hydroxychloroquine Sulfate (HCQ)

First Posted Date: 2020-04-14

Last Posted Date: 2021-05-12

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 48

Registration Number: NCT04345653

Locations: 🇺🇸
Hackensack Meridian Health - JFK Medical Center, Edison, New Jersey, United States

Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection

Phase 2

Terminated

Conditions: COVID-19

Interventions: Biological: Convalescent Plasma

First Posted Date: 2020-04-13

Last Posted Date: 2023-09-18

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 52

Registration Number: NCT04343755

Locations: 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States

AMNIOX CORD Study - Radical Prostatectomy With and Without Cryopreserved Umbilical Cord Allograft

Phase 2

Recruiting

Conditions: Prostate Cancer

Interventions: Procedure: Robot-Assisted Radical Prostatectomy
Biological: Cryopreserved Umbilical Cord Allograft

First Posted Date: 2020-02-10

Last Posted Date: 2024-12-27

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 100

Registration Number: NCT04263025

Locations: 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States

Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma

Phase 1

Recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Carfilzomib
Drug: Cyclophosphamide
Drug: Dexamethasone
Drug: Granulocyte Colony-Stimulating Factor

First Posted Date: 2019-04-10

Last Posted Date: 2024-07-19

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 18

Registration Number: NCT03909412

Locations: 🇺🇸
Hackensack Meridian Health - John Theurer Cancer Center, Hackensack, New Jersey, United States

Ketamine for Pain in the Emergency Department

Phase 4

Terminated

Conditions: Acute Pain

Interventions: Drug: Ketamine Injectable Product

First Posted Date: 2019-03-29

Last Posted Date: 2023-06-07

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 11

Registration Number: NCT03896230

Locations: 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States

DECIDE: Developing Tools for Lung Cancer Screening Discussion Improvement

Completed

Conditions: Lung Cancer
Smoking
Smoking, Cigarette
Smoking, Tobacco

Interventions: Behavioral: Cataldo Lung Cancer Stigma Scale (Smoking-Related Subscale)
Behavioral: Primary Care Clinicians' Lung Cancer Screening Survey
Behavioral: Patient Trust in the Medical
Behavioral: Decision Conflict Scale (DCS) - Lung Cancer Screening
Behavioral: Shared Decision Making Questionnaire (SDM-Q)- Patient
Behavioral: Stage of Readiness for Smoking Cessation - Contemplation Ladder

First Posted Date: 2019-03-27

Last Posted Date: 2024-08-23

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 654

Registration Number: NCT03891602

Locations: 🇺🇸
Kaiser Permanente Washington Health Research Institute, Seattle, Washington, United States

Parkinson's Disease Inpatient Clinical Knowledge and Management

Not Applicable

Terminated

Conditions: Parkinson Disease

Interventions: Device: Watch Rx system
Other: Parkinson's Disease Inpatient Clinical Knowledge and Management Program

First Posted Date: 2019-03-25

Last Posted Date: 2023-04-18

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 477

Registration Number: NCT03888287

Locations: 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States

Prostasomes as Diagnostic Tool for Prostate Cancer Detection

Suspended

Conditions: Prostate Cancer

Interventions: Diagnostic Test: Genetic analysis for the detection of prostasomes

First Posted Date: 2018-10-03

Last Posted Date: 2024-11-22

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 600

Registration Number: NCT03694483

Locations: 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States

Personal Resilience Empowerment Program Study

Not Applicable

Completed

Conditions: Cholangiocarcinoma
Liver Cancer
Pancreatic Cancer
Lung Cancer

Interventions: Behavioral: Personal Resilience Empowerment Program including 5 sessions with health coaches

First Posted Date: 2018-08-23

Last Posted Date: 2021-10-15

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 37

Registration Number: NCT03644173

Locations: 🇺🇸
Hackensack Meridian Health - Jersey Shore University Medical Center, Neptune, New Jersey, United States
🇺🇸
Hackensack Meridian Health - Riverview Medical Center, Red Bank, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy